Literature DB >> 6343225

Mechanisms of early allogeneic marrow graft rejection.

H von Melchner, P F Bartlett.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6343225     DOI: 10.1111/j.1600-065x.1983.tb01067.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  6 in total

1.  Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.

Authors:  T Iwasaki; T Hamano; K Saheki; T Kuroiwa; Y Kataoka; Y Takemoto; A Ogata; J Fujimoto; E Kakishita
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.

Authors:  G Dennert; C Knobloch; S Sugawara; B Yankelevich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cells.

Authors:  P C Doherty; J E Allan; W Allan
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

4.  Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation.

Authors:  Y Reisner; I Ben-Bassat; D Douer; A Kaploon; E Schwartz; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Authors:  A Gratwohl; A Sureda; J Cornelissen; J Apperley; P Dreger; R Duarte; H T Greinix; E Mc Grath; N Kroeger; F Lanza; A Nagler; J A Snowden; D Niederwieser; R Brand
Journal:  Leukemia       Date:  2017-03-08       Impact factor: 11.528

6.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.